Hangzhou Sciwind Biosciences Co., Ltd.
Clinical trials sponsored by Hangzhou Sciwind Biosciences Co., Ltd., explained in plain language.
-
New obesity drug tested in teens: safe?
Disease control OngoingThis early-stage study tests an experimental drug called XW003 in 48 Chinese adolescents with obesity. The main goal is to check safety and side effects, while also measuring how the drug works in the body and its effect on weight. Participants must have tried diet and exercise f…
Phase: PHASE1 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
New obesity drug XW003 takes on semaglutide in Head-to-Head trial
Disease control OngoingThis study tests whether a new drug called XW003 works better than semaglutide (a known weight-loss medication) for Chinese adults with obesity. About 163 participants with a BMI of 30 or higher will receive either drug, and researchers will measure weight loss, waist size, and s…
Phase: PHASE2 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 07:57 UTC